Ask AI
ProCE Banner Activity

Overview of Immunotherapy for Early-Stage NSCLC and Clinical Factors Influencing Response to Checkpoint Inhibition

Slideset Download

Download these slides from a live CCO Webinar for an overview of the evolving immunotherapy landscape for early-stage NSCLC along with coverage on how cachexia, immune-related adverse events, and disparities in care impact outcomes for patients with NSCLC receiving checkpoint inhibitor therapy.

Released: June 24, 2021

Expiration: June 23, 2022

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

This activity was developed from a series of programs cosupported by educational grants from

Helsinn Healthcare SA

Regeneron Pharmaceuticals, Inc.

Sanofi Genzyme